thiazoles has been researched along with ADPKD in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aiba, A; Harris, PC; Higashihara, E; Horie, S; Katsuki, M; Kitamura, T; Kurabayashi, M; Muto, S; Nagai, R; Nakamura, K; Nakao, K; Saito, Y; Tomita, K | 1 |
1 other study(ies) available for thiazoles and ADPKD
Article | Year |
---|---|
Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant.
Topics: Animals; beta Catenin; Cytoskeletal Proteins; Endothelium; Kidney; Mice; Phenotype; Pioglitazone; Polycystic Kidney, Autosomal Dominant; Proteins; Proto-Oncogene Proteins c-myc; Sequence Deletion; Thiazoles; Thiazolidinediones; Trans-Activators; TRPP Cation Channels | 2002 |